Current treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany

被引:0
|
作者
Vogt, D. [1 ]
Haritoglou, C. [2 ]
Nicoletti, V. [1 ]
Kortuem, F. C. [3 ]
Deiters, V. [4 ]
Hoerauf, H. [5 ]
Wolf, A. [1 ]
Schumann, R. G. [1 ,6 ]
机构
[1] Univ Klinikum Ulm, Klin Augenheilkunde, Prittwitzstr 43, D-89075 Ulm, Germany
[2] Augenklin Herzog Carl Theodor, Munich, Germany
[3] Univ Klinikum Tubingen, Augenklinik, Tubingen, Germany
[4] Ludwig Maximilians Univ Munchen, Augenklin Univ Munchen, Munich, Germany
[5] Univ Med Gottingen, Augenklinik, Gottingen, Germany
[6] Augenzentrum & Gefassmed Munchen Schwabing, Munich, Germany
来源
OPHTHALMOLOGIE | 2024年 / 121卷 / 12期
关键词
Macular hole; Vitrectomy; Vitreolysis; Vitreomacular traction; Ocriplasmin; PARS-PLANA VITRECTOMY; PNEUMATIC VITREOLYSIS; OCRIPLASMIN;
D O I
10.1007/s00347-024-02118-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To evaluate the different treatment strategies for eyes with vitreomacular traction (VMT) and macular holes (MF) regarding the indications and initiation of treatment. ObjectiveThe aim of this study is to facilitate clinical decision making by presenting the opinions of experienced retinal specialists in the context of the current literature and the changed approval situation for ocriplasmin. Material and methods: Members of the German Retina Society (RG) were questioned in an online survey. Based on a literature review a 100-question questionnaire was created and sent to all members of the RG via an electronic link to the online platform "LimeSurvey". Voluntary participation was possible from 15 October 2021 to 15 November 2021. Data collection and statistical analysis were anonymized. Results: The responses of the 115 participants were congruent with the presentation of the new S1 guidelines on this topic. The indications for active treatment of focal VMT without MF were postponed in favor of watchful waiting, with the individual symptoms of the patient playing a major role in the proposed temporal management. The results on the indications for vitrectomy are consistent and convincingly confirm the opinions on the efficacy and risk assessment of this therapeutic procedure. Conclusion: The results presented provide an overview of the consensus and controversies in the current treatment options for VMT and MF. With the help of a homogeneous and experienced group of retinal experts, it was possible to develop individual treatment strategies.
引用
收藏
页码:973 / 984
页数:12
相关论文
共 48 条
  • [31] Successful treatment of macular holes associated with peripheral retinal vascular tumours
    G Clare
    D Yorston
    D H Charteris
    G W Aylward
    Eye, 2007, 21 : 419 - 420
  • [32] Successful treatment of macular holes associated with peripheral retinal vascular tumours
    Clare, G.
    Yorston, D.
    Charteris, D. H.
    Aylward, G. W.
    EYE, 2007, 21 (03) : 419 - 420
  • [33] AUTOLOGOUS RETINAL TRANSPLANTATION AS A PRIMARY TREATMENT FOR LARGE CHRONIC MACULAR HOLES
    Tanaka, Shin
    Inoue, Maiko
    Inoue, Tatsuya
    Yamakawa, Tadashi
    Uchio, Eiichi
    Grewal, Dilraj S.
    Mahmoud, Tamer H.
    Kadonosono, Kazuaki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (10): : 1938 - 1945
  • [34] Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences
    Maier, M.
    Abraham, S.
    Frank, C.
    Feucht, N.
    Lohmann, C. P.
    OPHTHALMOLOGE, 2015, 112 (12): : 990 - 994
  • [35] Current strategies for macular hole surgery in Germany, Austria and Switzerland
    Schaal, K. B.
    Bartz-Schmidt, K. U.
    Dithmar, S.
    OPHTHALMOLOGE, 2006, 103 (11): : 922 - 926
  • [36] VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Krishnan, Radhika
    Arora, Rashi
    De Salvo, Gabriella
    Stinghe, Alina
    Severn, Philip S.
    Pal, Bishwanath
    Goverdhan, Srinivas
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (09): : 1750 - 1756
  • [37] Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
    Muqit, Mahiul M. K.
    Hamilton, Robin
    Ho, Jason
    Tucker, Sally
    Buck, Helen
    PLOS ONE, 2018, 13 (05):
  • [38] Lamellar macular holes-In the center of vitreomacular interface diseases. Pathophysiology, spontaneous courses and treatment concepts
    Klaas, Julian E.
    Lommatzsch, Albrecht
    Krohne, Tim U.
    Hattenbach, Lars-Olof
    Priglinger, Siegfried
    OPHTHALMOLOGIE, 2024, 121 (06): : 452 - 461
  • [39] Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study
    Meyer, Carsten H.
    Szurman, Peter
    Haritoglou, Christos
    Maier, Mathias
    Wolf, Armin
    Lytvynchuk, Lyubomyr
    Priglinger, Siegfried
    Hillenkamp, Jost
    Wachtlin, Joachim
    Becker, Matthias
    Mennel, Stefan
    Koss, Michael J.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (10) : 2151 - 2161
  • [40] Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists
    Ogura, Yuichiro
    Shiraga, Fumio
    Terasaki, Hiroko
    Ohji, Masahito
    Ishida, Susumu
    Sakamoto, Taiji
    Hirakata, Akito
    Ishibashi, Tatsuro
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (01) : 43 - 50